Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
Clinical trial NCT06041529 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06041529
- Sponsor
- Yuhan Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2026-02-28
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.